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The generation of immune responses is dependent  upon interactions among three 
types  of cells:  T,  B,  and  macrophages.  These  interactions  are  regulated  by  genes 
located within the immune response or I region and HLA-D region of the murine and 
human major histocompatibility complexes (MHC), 1 respectively, (1-8). The mech- 
anisms by which these I or HLA-D region genes regulate cellular interactions is not 
well understood.  However, they are believed to be mediated by I or HLA-D region 
glycoprotein products expressed on the cell surface of B  cells and macrophages and 
known  as  Ia  (I  region-associated)  molecules  (9-14).  T  cells  possess  allele-specific 
receptors that recognize Ia molecules on B cells and macrophages (15, 16). Recognition 
of these molecules by T  cells, either in combination with antigen or alone, is a requisite 
for development of T  cell function, i.e., helper function for antibody production by B 
cells and cell-mediated immunity. Because Ia molecules are highly polymorphic, with 
more than 20 and  12 alleles having been described in mouse and man, respectively, 
isolated T  ceils from one individual possessing receptors for its own Ia molecules will 
not interact with B cells and/or macrophages from an individual with a  different set 
of Ia molecules. However, differentiation of bone marrow or spleen stem cells in an 
environment containing "foreign" Ia molecules will result  in the development of T 
cells  that  can  now  specifically recognize  the  "foreign"  Ia  molecules  (17-20).  This 
differentiation, with concomitant development of receptors specific for Ia, apparently 
takes place in the thymus (21-23). 
In mice, two families of Ia molecules encoded by the I-A and I-E subregions have 
been  identified  and  characterized  (24).  Both  I-A and  I-E molecules consist  of two 
noncovalently  associated  polypeptide  subunits.  The  large  (Aa)  and  small  (Aft) 
subunits of I-A have molecular weights of 35,000 and 26,000, respectively, while the 
large  (Ea)  and  small  (Eft)  subunits  of I-E have  molecular weights  of 32,000  and 
29,000,  respectively (25).  Despite connotations  of similarity  denoted  by both being 
generally  referred  to  as  Ia  molecules,  the  I-A  and  I-E  molecules  are  structurally 
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distinct  based  on  partial  N-terminal  sequence  and  peptide  map  analysis  (26-29). 
Furthermore, I-A and I-E molecules display different patterns of structural variability. 
When allotypic I-E molecules are structurally compared, their small  (fl) subunits are 
found to be very different,  whereas  their  large  (a)  subunits  are  generally  invariant 
(25,  30).  I-A molecules,  in  contrast,  display  structural  variability  in  both  subunits 
when allotypes are compared (25, 31). In this respect, it is intriguing to note that the 
genes  coding  for  the  three  variable  subunits,  Aa,  Aft,  and  Eft,  are  tightly  linked, 
whereas  the  gene  encoding  the  invariant  Ea  subunit  is  apparently  separate  and 
distinct  (30-33). 
Until  recently, only one group of Ia molecules had  been identified  in  man.  This 
family  of Ia  molecules,  known  as  HLA-DR  (for  D  region-related),  is  structurally 
homologous  to  the  murine  I-E  subregion  molecules  on  the  basis  of amino  acid 
sequence analysis (27). We have recently been able to identify the human equivalents 
to the murine I-A subregion molecule using a  monoclonal antibody prepared  in our 
laboratory (34). We describe here the isolation and further biochemical properties of 
these molecules, which we have designated HLA-DS for "second D-region locus." 
Materials  and Methods 
Cell Lines.  All human cell lines used in this study are homozygous by consanguinity at the 
HLA locus. Their HLA phenotypes are described in Table I. The human lymphoblastoid cell 
lines  with  a  GM  designation  were  obtained  from  the  Human  Mutant  Cell  Repository in 
Camden, N  J, as was the marmoset cell line GM3158(M). The human lymphoblastoid cell lines 
with  an  LG  designation  were  obtained  from  the  Leibold-Gatti  collection  (Department  of 
Pediatrics, UCLA Medical Center, Los Angeles, CA). 
Isolation of Ia Molecules.  Cells  (2 ×  10  a) were radiolabeled in overnight culture in 5 ml of 
RPMI  1640  (lacking the  amino  acid  that  was added  in  radioactive  form)  containing  10% 
dialyzed fetal bovine serum and 1-5 mCi of radioactive amino acid. After washing the cells in 
phosphate-buffered saline (PBS), membrane proteins were solubilized with 5 ml of 0.5% Triton 
X-100 in 0.01  M  Tris, pH  7.4  (buffer A). The supernatant  was incubated overnight at 4°C 
with lentil leetin coupled to Sepharose 4B. After extensive washing of the lentil lectin column, 
glycoproteins were eluted with 2% a-methyl mannoside in buffer A. The glycoprotein fraction 
was incubated  overnight  at  4°C with  0.2  ml  of immunoadsorbent  prepared  by covalently 
coupling monoclonal antibody to cyanogen bromide-activated Sepharose 4B (Pharmacia Fine 
Chemicals, Div. of Pharmacia, Inc., Piscataway, N  J) at a ratio of 1 ml ascites fluid/g Sepharose 
followed by suspension in 0.01 M Tris, pH 8.2, containing 0.15 M NaCI and 0.5% deoxycholate 
(buffer B). After extensive washing of the immunoadsorbent with buffer B, followed by two 
washes with buffer B lacking salt, the purified Ia molecules were eluted with 0.05 M diethylam- 
ine containing 0.5% deoxycholate. The samples were lyophilized, redissolved in 1.0 ml of H~O, 
and  precipitated  with  3  ml  acetone in  the  presence  of 100 ~g of human  gamma globulin 
(HGG). The precipitate was washed once with acetone, air-dried,  and redissolved in  100/~1 
TABLE  I 
HLA Phenotypes  of Lymphoblastoid Cell Lines 
Name  Cell Line  HLA-A  HLA-B  HLA-C  D  DR  designation 
GM3107  PGF  3  7  2  2 
GM3163  LBF  30  13  2  7 
LG2  JB  2  27  1  1 
LG 10  MAu  29  12  7  7 
LG 14  ALT  1  8  6  3  3 
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Laemmli nonreducing  sample buffer (35). After electrophoresis on 12.5% polyacrylamide gels, 
proteins were  eluted from  1-mm gel slices by overnight incubation with 0.5  ml of a  0.01% 
sodium dodecyl sulfate (SDS)  solution. The Ia a  and fl subunits were localized by counting 
aliquots of the eluted material. 
Peptide Map Analysis.  Ia polypeptide subunits purified by SDS-PAGE and labeled with 
50,000  cpm of [nH]phenylalanine or 40,000  cpm of [14C]phenylalanine were combined and 
lyophilized. 
R~VUCTION/ALK~:taXION.  The  lyophilized  samples  were  dissolved  in  800  pl  H20  and 
combined with 100 pl ofa dithiothreitol (DTT) solution (15.4 mg/100 #1) before incubation at 
37°C for 3 h. Recrystallized iodoacetamide (200 #1 of a 46 mg/200 #1 solution) was added, and 
the samples were incubated at 37°C. After 10 min, 50 pl of 2 N NaOH was added, followed 10 
min later by a further addition of 25 #1 of 2 N NaOH. Finally, the samples were incubated for 
10 min followed by the addition of 7.8 mg of DTT. 
TRICHLOROACETIC  ACID (TEA) PRECIPITATION.  After the addition of 1 mg of HGG, the samples 
were vortexed and mixed with 0.15  ml of 100% TCA. After incubation at 4°C for  1 h, the 
samples were centrifuged at 3,000 rpm for 5 min. The resultant precipitates were washed once 
with 2 ml of 5% TCA, washed twice with acetone, and air dried overnight. 
TRYPSIN DmESTION.  After reduction/alkylation and TCA precipitation, the dried precipi- 
tates were dissolved in 0.5 ml of 0.1 N NFLtHCO3, pH 8.0.  10 pl of a solution of 10 mg TPCK 
trypsin/ml H20 were added to each sample, followed by incubation  at 37°C for 1 h. Afterward, 
an additional 100/~l  of TPCK trypsin was added,  and incubation continued another 2  h, 
followed  by the addition of 100/tl of 10 M  isoelectric  focusing (IEF) sample buffer (a  10 ml 
solution contains 0.4% Triton X-100, 0.5 ml ampholine [LKB] mixture (37.5% pH 3.5-5.0, 25% 
pH 4.0-6.0, 37.5% pH 5.0-8.0), 1.05 ml H20, 5.82 g urea). The samples were then lyophilized. 
IEF 
(a) Preparation of gels. Formula for seven gels:  16.94 g urea,  1.16 ml Triton X-100,  1.46 ml 
ampholine mixture, 5.0 ml of a solution containing 20% acrylamide 1% Bis, and 9.88 ml H20. 
Heat and stir to dissolve, bring to room temperature, add 0.15 ml 10% ammonium persulfate, 
and fill 7-mm ×  13-cm gel tubes to the  10-cm level. Overlay with IEF sample buffer diluted 
fourfold. 
(b) Running buffers. These buffers are made fresh. The upper buffer is 0.1 N NaOH. The lower 
buffer is 0.01 M  HaPO4. 
(c) Preparation of  samples. Dissolve lyophilized  sample in 60 v,l HaO and 5/~12-mercaptoethanol. 
(d)  To run gels. Cover bottom of each gel  tube with dialysis tubing held in place with a 
rubber band. Place tubes in electrophoresis chamber, add  100 pl 6.7 M  IEF sample buffer to 
each, and prerun for 1 h at constant power, 0.1 W/gel. Apply the sample under the 6.7 M IEF 
sample buffer and run as above for 6 l& h. 
(e) Freeze gels, slice in l-ram sections,  and elute in 0.5 ml H20 overnight. Determine pH 
gradient, add 4 ml scintillation fluid, and count in scintillation counter. Adjust for channel 
spillover, and plot cpm against slice number. 
Amino Acid Sequence Analysis.  Partial N-terminal sequencing using microamounts of radio- 
labeled protein was performed as described (36). Ia subunits radiolabeled with single tritiated 
amino acids were purified by SDS polyacrylamide gel  electrophoresis (PAGE) as described 
above. After elution from the polyacrylamide gel, samples were dialyzed extensively against 
0.01%  SDS.  3  mg of sperm whale myoglobin was  added  to  each  sample, which  was  then 
sequenced on an 890C Beckman sequenator (Beckman Instruments, Inc., Fullerton, CA). The 
sequentially released thiazolanones were converted to  thiohydantoins with 0.1  N  HC1  and 
extracted with ethyl acetate. Small aliquots of the extract (5%) were analyzed by high-pressure 
liquid chromatography to ascertain repetitive yield. The remainder of the sample was counted 
in a liquid scintillation counter. 
Complete N-terminal sequence analysis was performed as described by Shively et al. (37). 1- 
2 nmol of Ia molecules was purified from 10  x° cells by immunoadsorbtion  using a small amount 
of radiolabeled protein as tracer.  After lyophilization and dissolution in water as described 
above, Ia molecules were  precipitated with  acetone without  the  addition of carrier  HGG. 
Isolated a  and fl subunits were obtained after further purification by SDS-PAGE. 
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purified by immunoadsorbtion as described above, except that the final washes  and elution 
from the immunosorbent were done in the presence of Triton X-100 instead of deoxycholate. 
The samples were lyophilized, resuspended  in  25 /~l sample buffer, and  electrophoresed as 
described by O'Farrell (38) with the following modifications, some of which were adapted from 
McMillan et al. (39): (a) 2-mercaptoethanol was eliminated from all reagents; (b) the sample 
buffer and IEF gel were prepared according to McMillan et al.;  (c) the gel overlay solution is 
composed of sample buffer diluted to 6 M urea;  (d) the sample overlay buffer is composed of 
6 M sample buffer containing 0.05% aspartic and glutamic acid; (e) samples were electropho- 
resed according to McMiUan et al. (39); (f) SDS-PAGE was performed according to O'Farrell 
(38) on 12.5% polyacrylamide gels. 
Results 
Identification of  Marmoset and Human L A Subregion-like Molecules.  The studies described 
here  were  initiated  with  the  intention  of isolating  and  characterizing  the  human 
homologs of murine Ia antigens. To achieve this goal, we immunized BALB/c mice 
with  a  mixture  of  lymphoblastoid  cell  lines  GM3158(M),  GM3107(DR2),  and 
GM3163(DR7), obtained from the Human Mutant Cell Repository in Camden, N J, 
to produce monoelonal antibodies  (MAb)  directed against human Ia molecules. Of 
four monoclonal antibodies produced by this immunization, which were reactive with 
these cell lines, studies with just two monoclonal antibodies, designated SG157  and 
SG 171, will be described here. 
When used in an indirect immunoprecipitation assay, these two antibodies bound 
molecules  having  SDS-PAGE  profiles  depicted  in  Fig.  1.  Although  the  profiles 
obtained using SG157 or SG171  with either GM3107(DR2)  or GM3163(DR7)  cells 
were basically identical, the differences in profiles observed when these two antibodies 
were tested with GM3158(M)  cells suggested that SG157  and SG171  were reacting 
with different  molecules. This was confirmed by peptide map analysis and 2-D gel 
electrophoresis  (34).  To  determine  whether  SG157  and  SG171  were  reacting  with 
molecules related to HLA-DR, both MAb were used in conjunction with a  radiola- 
beled glycoprotein fraction from GM3158(M) cells to isolate molecules that were then 
subjected  to  partial  N-terminal  sequence  analysis. The results  of this  analysis  (34) 
indicated  that  SG157  reacts with an  HLA°DR  (I-E-like) molecule, whereas  SG171 
reacts with a molecule structurally homologous to the murine I-A subregion molecule. 
During the course of these initial studies,  it became apparent  that GM3158  (M) 
had  properties  quite  distinct  from GM3107  and  GM3163  and  from other  human 
lymphoblastoid cell lines. Although  the other cell lines were pleomorphie and grew 
only in suspension, GM3158(M)  grew both in suspension as round cells and on the 
surface of the tissue culture flasks, where they took on a  fibroblast-like morphology. 
Furthermore,  GM3158(M)  was  the  only cell  line  that  secreted  large  quantities  of 
Epstein-Barr virus. This latter property is especially unusual for human cell lines and 
made  us  suspicious  of the  origins  of GM3158(M).  When  GM3158(M)  was  subse- 
quently  karyotyped,  it  was  found  to  be  of marmoset  and  not  human  origin.  In 
contrast, both GM3107(DR2)  and GM3163(DR7)  were found to be of human origin. 
Because we had not previously worked with marmoset cells, it was unlikely that our 
laboratory was  the  source  of contamination,  and,  indeed,  when  GM3158(M)  was 
karyotyped immediately after receipt  from the Human Mutant  Cell  Repository,  it 
was  found  to be of marmoset origin.  Thus,  these  cells were most likely already of 
marmoset origin when originally donated to the repository. Marmoset cell contami- 
nation is apparently due to the fact that Epstein-Barr virus used to transform human 554  HLA-DS,  A SECOND  FAMILY OF HUMAN  Ia MOLECULES 
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FxG.  1.  SDS-PAGE profiles of molecules isolated from cell lines GM3107(DR2), GM3163(DR7), 
and GM3158(M) by immunopreeipitation  (40) with monoclonal antibodies SG157 (left column) 
and SG171 (right column). The inset shows the SDS-PAGE profile obtained from a mixture  of 
SG157-precipitated  material  ([3H]phenylalanine  labeled)  and  SG171-precipitated  material 
([~S]methionine labeled)  isolated from GM3158(M)  and established the differences in molecular 
weights between these two complexes. All samples were electrophoresed under nonreducing condi- 
tions. The (x and/~ subunits have molecular weights of ~37,000 and 29,000, respectively. 
lymphocytes is routinely obtained from transformed marmoset cells from which it is 
secreted  in  large  quantities.  Inadequate  removal of marmoset  cells from  the  virus 
extract before transformation may result in contamination with marmoset cells that 
rapidly outgrow the human lymphocytes. We have since found that several other cell 
lines being used by other investigators and believed to be of human origin are actually 
marmoset. All displayed the unusual growth properties of GM3158(M)  and possessed 
the I-A subregion-like molecule. 
Because our intention now was to isolate the human equivalent to the murine I-A 
subregion-like  molecule,  we  turned  our  attention  to  the  two  human  cell  lines, 
GM3107(DR2)  and GM3163(DR7),  that were under study in our laboratory. 2-D gel 
analysis of GM3107(DR2)  molecules binding to SG 157 and SG 171  revealed virtually SANNA  M.  GOYERT,  JOHN  E.  SHIVELY,  AND  JACK  SILVER  555 
identical profiles (Fig. 2). This was quite surprising in view of the fact that the DR- 
like and I-A subregion-like molecules from the marmoset cell line, GM3158(M), could 
easily be distinguished by 2-D gel analysis. The 2-D gel results suggested, therefore, 
that  in  contrast  to  GM3158(M),  where  SG157  and  SGI71  reacted  with  different 
molecules,  these  MAb  reacted  with  identical  molecules  when  used  with 
GM3107(DR2)  cells.  Furthermore, because we knew from our analysis of the mar- 
moset cell line GM3158(M)  and from other previous studies using human cell lines 
(40)  that  SG157  reacts  with  HLA-DR  molecules,  the  identity in  2-D  gel  profiles 
suggested that SG171  was also reacting with HLA-DR molecules. Indeed, when the 
Fro.  2.  2-D  gel  analysis of proteins  isolated  from GM3107(DR2)  with  SG157  (top)  and  SG171 
(bottom).  It is important  to point out  that  the ot subunit, although appearing  as a  single spot, is 
actually  represented  by four closely migrating spots when  the x-ray  film  is exposed  for a  shorter 
period. 
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Fxo.  3.  Tryptic  peptide  comparison  of  0t  (left)  and  ,8  (right)  polypeptides  isolated  from 
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peptide maps of molecules from GM3107(DR2)  binding to SG157 and SG171 were 
compared, they were found to be identical (Fig. 3). Thus, although SG 171 bound I-A 
subregion-like molecules from  the  marmoset,  it  not  only failed  to  bind  any  easily 
detectable I-A subregion-like molecules from the human cell line GM3107(DR2), but 
also cross-reacted with HLA-DR. To rule out the possibility that SG 171 was composed 
of two different monoclonal antibodies, one reacting with marmoset I-A and the other 
with human DR molecules, we performed a competitive inhibition test. The human 
cell  line GM3107(DR2)  completely absorbed  the  reactivity of SG171  against  the 
marmoset cell line GM3158(M). 
The results of studies with the human cell line GM3163(DR7) were, however, quite 
different from those with GM3107(DR2). Peptide map profiles of molecules binding 
to SG157 and  SG171  were very different from each other (Fig. 4).  There were two 
obvious ways to account for these differences: (a) SG157 and SG171 were binding to 
totally unrelated  molecules,  or  (b)  SG157  was  binding  HLA-DR  molecules while 
SG171, which cross-reacted with human  HLA-DR and marmoset I-A, was binding 
both HLA-DR and the human equivalent to the I-A subregion-like molecules. The 
results  of 2-D  gel  analysis  (Fig.  5)  confirm the  latter  interpretation.  The  2-D  gel 
profiles of molecules from GM3163(DR7)  cells binding to SG157 and  SG171  were 
identical except for three additional basic spots corresponding to a molecule of 29,000 
mol wt (i.e., the fl subunit)  that was present in the SG171 profile. These three more 
basic spots presumably represent the small subunit  of I-A subregion-like molecules 
(DSfl), while  the  adjoining  series of acidic  spots  presumably  represents  the  DRfl 
subunit.  This  hypothesis  was  confirmed  in  a  depletion  experiment  in  which  the 
glycoprotein extract from GM3163(DR7)  was  first depleted as much as possible of 
SG 157 (DR-binding) reactivity and then reacted with SG171. As can be seen, SG 157 
nearly completely removes the  more acidic  (DRfl)  spots  while leaving behind  the 
more basis  (DSfl) spots.  In contrast to the two series of low molecular weight spots 
corresponding to the DRfl and DSfl subunits, only a single spot was observed in the 
37,000  mol  wt  range,  suggesting  that  the  DRa  and  DSa  subunits  had  identical 
molecular weights  and  charge.  Confirmation  of this  proposal  as  well  as  the  dual 
specificity of SG17 t  (i.e., DR and DS) was obtained by N-terminal sequence analysis 
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FIG.  4.  Peptide  map  comparisons  of  ct  (left)  and  fl  (right)  polypeptides  isolated  from 
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Fro. 5.  2-D  gel  analysis  of proteins  isolated  from  GM3163(DR7)  with  SG157 (top),  SG171 
(middle), and SG 171, after deplet  ion of  t he glycoprotein extract of SG  157-binding protein 0oot  tom). 
Depletion  was accomplished  by passing a  GM3163(DR7)  glycoprotein  extract over  an  SG157- 
immunoadsorbent  twice before using an SG 171-immunoadsorbent. 
TABLE II 
Amino Acid Sequences of Large (or) Subunits* 
Step number 
1  2  3  4  5  6  7  8  9  10  II  12  13  14  15  16  17  18  19  20  21  22  23  24 
DSa  E  D  I  V  A  D  H  V  A  A  Y  G  V  N  L  Y  []  S  Y  G  P  M  GM31580VI)  G  Q 
DSa  E  D  I  V  A  D  H  V  A  A  Y  G  V  N  L  Y  ['~  S  Y  G  P  M  G  Q 
GM3163 
DRa  I  K  E  E  H  V  I  I  Q  A  E  F  Y  L  N  P  D  Q  S  G  E  F  M  F 
LG2  DRa  I  K  E  E  H  V  I  I  Q  A  E  F  Y  L  N  P  D  Q  S  G  E  F  M  F 
* Glycoprotein extracts  from  10 l° cells of the human cell lines LG2(DR1)  and GM3163(DR7)  and the marmoset cell line GM3158(M) were adsorbed 
onto SG 17 l-lmmunoadsorbent columns, and HLA-DR and DS molecules were isolated as described in Materials and Methods. The component a  and 
/i' subunits were purified by SDS-PAGE, dated from the gels, dialyzed, and sequenced  in the presence of polybrene as described (37). The marmoset 
(GM3158) and human  CLG2) a  chains gave single, although very different,  N-terminal sequences. The a  subunit  isolated from GM3163(DR7)  gave 
a mixed sequence, one corresponding to the a  subunit of LG2 (DRa) and the other corresponding almost perfectly to the marmoset a  sequence (DSa). 
Sequences are given using the single-letter amino acid code. Boxed residues indicate differences between human and marmoset DSa. 
of  the  large  molecular  weight  component  (37,000  mol  wt)  isolated  from 
GM3163(DR7)  cells with SG171.  Results of this analysis and a  comparison with the 
amino  acid sequences  of the  DRa  and  the  marmoset  Aa  subunits  reveal  that  this 
large molecular weight component  (37,000  mol wt)  from  GM3163(DR7)  consists of 
two molecules, one that has a  sequence identical to that of the DRa  subunit isolated 
from  human  cell  lines  and  a  second  molecule  whose  sequence  is  identical  to  the 
marmoset Aa subunit in 23 of 24 residues (Table II). 558  HLA-DS, A  SECOND  FAMILY OF  HUMAN  Ia  MOLECULES 
Specificity  of the MAb  SG171.  The ability of SG171  to isolate  I-A subregion-like 
molecules from GM3163(DR7)  but not from GM3107(DR2) could be accounted for 
in  two  possible  ways:  (a)  only some  human  cell  lines  express  I-A  subregion-like 
molecules, possibly because of their being at different stages of differentiation, or (b) 
SG171  is  a  polymorphic antibody,  i.e.,  it  recognizes only certain  allotypes of I-A 
subregion-like molecules. To distinguish between these two possibilities, we examined, 
by peptide mapping and/or 2-D gel analysis, several other human  lymphoblastoid 
cell lines, LG2(DR1), LG14(DR3), LG10(DR7), and LG36(DR7), for their ability to 
express I-A subregion-like molecules reactive with SG 171. When the molecules from 
LG2(DR1), reactive with SG157  and SG171, were compared by peptide  mapping 
and 2-D gel electrophoresis, they were found to be identical. Similarly, the molecules 
from  LG14(DR3),  reactive  with  SG157  and  SG171,  displayed  identical  2-D  gel 
patterns.  Thus, just  as was  found for cell line GM3107(DR2),  SG171  bound only 
HLA-DR molecules from cell lines LG2(DR1) and LG14(DR3). In contrast to these 
observations, when SGI71 was tested on LG10(DR7) and LG36(DR7), the 2-D gel 
profiles  obtained  were  virtually  identical  to  those  observed  with  the  cell  line 
GM3163(DR7), i.e., three extra basic spots characteristic of the small subunit of I-A 
subregion-like molecules that  were absent when these cells were tested with SG157 
(Fig. 6). It is crucial to the interpretation of this data that we point out that all three 
cell lines that  express I-A subregion-like molecules reactive with SG171  have been 
typed as DR7, and, indeed, we confirmed by peptide mapping (40) that they express 
identical DR molecules. Thus, SG171 reacts only with I-A subregion-like molecules 
found on DR7 cell lines. This observation has several important implications that will 
be discussed later. 
Isolation of I-A Subregion-like Molecules from Other Human Cell Lines.  The specificity of 
SG171  for I-A subregion-like molecules present only on DR7 cell lines made SG171 
of limited use for isolating I-A subregion-like molecules from cell lines of other DR 
types. To circumvent this obstacle, we decided to prepare a  more broadly reactive 
antiserum by immunizing rabbits and mice with I-A subregion-like proteins purified 
from the marmoset cell line GM3158(M). This antiserum, Rb03, reacts solely with 
the I-A subregion-like molecules [i.e., no evidence of cross-reaction with DR from the 
DR7 cell line GM3163(DR7)]  (Fig. 7). Furthermore, when used in conjunction with 
GM3107(DR2) cells, the rabbit antiserum binds a molecule represented by a series of 
spots of ~29,000 mol wt that are distinguishable from the DRfl subunit isolated with 
SG157  (Fig. 8). However, the DSa and DRa subunits are still indistinguishable,  as 
was observed for the GM3163(DRT)  cells.  Partial N-terminal sequence analyses of 
the large (a) and small (fl) subunits from GM3107(DR2) and LG10(DR7) binding to 
the rabbit antiserum confirm their assignment as HLA-DS (Table III). Except for the 
absence of phenylalanine residues at position  14, which is present  in the marmoset 
molecule, the sequences obtained are consistent with their assignment as DS molecules. 
Furthermore, no evidence of DR-like sequences is observed. Also, note that the DSa 
subunits isolated from GM3107 (DR2) and LG 10 (DR 7) differ at position 11, indicat - 
ing  that  DSa  subunits  are  polymorphic.  These  results  clearly  demonstrate  that 
GM3107(DR2)  cells  express  an  I-A  subregion-like  (DS)  molecule  distinct  from 
HLA-DR and detectable with the rabbit antiserum. 
Discussion 
An  understanding  of the  basic  mechanisms  that  underlie  immune  regulation 
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Fxo. 6.  2-D gel analysis  of proteins isolated from LGI0(DR7) and LG36(DR7) with SG157 (a and 
c, respectively)  and SG171 Co and d, respectively). 
interactions among immunocompetent cells. Having biochemically defined two such 
families  of molecules  in  mice,  I-A and  I-E,  known  collectively as  Ia  for  immune- 
response associated, we extended our studies to man. We have previously shown that 
human HLA-DR molecules initially described by Springer et al. (41)  are structurally 
equivalent  to  the  routine  I-E  molecules.  This  paper  describes  the  isolation  and 
biochemical properties of the human equivalent to the murine I-A molecule, hence- 
forth known as HLA-DS (for second D-region locus). 
The two monoclonal antibodies used in this study, SG157 and SG171, display very 
different specificities for human Ia molecules.  SG157 reacts with  HLA-DR from all 
human  cell  lines  tested  (40)  and  with  its  structural  equivalent  in  marmoset.  In 
contrast, SG171  reacts with DS molecules from marmoset and from human cell lines 
that are DR7. Thus, SG171  is a polymorphic antibody in that it reacts with only one 
allotype of DS molecule (henceforth known as DS7); i.e., those associated with HLA- 
DR7  cell  lines.  However, the situation  is complicated by the  fact  that  SG171  also 560  HLA-DS,  A  SECOND  FAMILY  OF  HUMAN  Ia  MOLECULES 
Fro.  7.  2-D gel analysis of proteins isolated from GM3163(DR7)  with SG171  (top)  and rabbit 
anti-marmoset I-A serum (bottom). 
FIG.  8.  2-D gel analysis of proteins isolated from GM3107(DR2) with SG157 (a) or rabbit anti- 
marmoset I-A serum (b). Panel c represents a mixture of samples a and b and shows that, although 
DR2 and DS2 are very similar by this method of analysis, they are nevertheless distinguishable. 
cross-reacts with  HLA-DR  molecules  from  all  human  cell  lines,  although  this cross- 
reaction is not observed in the marmoset. Thus, some antigenic determinant  or epitope 
is common  to DS7 and  all HLA-DR  allotypes. SANNA M. GOYERT, JOHN  E.  SHIVELY,  AND JACK SILVER 
TABLE III 
Partial N-Terminal Sequences of HLA-DS Molecules Isolated with Rb03* 
561 
Step number 
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
GM3163(DR7)a:~  E  D  A  D  H  A  A  G  V  N  L  Q  S  G 
LG 10(DR7)a 
GM3107(DR2)a 
GM3158(M)a§  F 
LG10(DR7)# 
GM3107(DR2)fl 
* HLA-DS molecules were isolated from LG10(DR7) cells radiolabeled with [aH]tyrosine and [aH]phenyl- 
alanine and  from GM3107(DR2) cells radiolabeled with [nH]isoleucine, [ZH]valine, [nH]tyrosine, and 
[3H]phenylalanine, using Rb03 antiserum and protein-A agarose. DSa and fl subunits were purified by 
SDS-PAGE and sequenced as described in Materials and Methods. Sequence identities are enclosed, and 
sequence differences are denoted by dashes. 
:1: This sequence was obtained from protein purified with the monoclonal antibody SG 171, as described in 
the text. 
§ This was taken from ref. 34 and represents the marmoset I-A subregion-like molecule. 
The allotype specificity of SG 171 and its cross-reactivity with HLA-DR limited the 
usefulness  of SG171  for identifying I-A-like molecules  from other cell  lines.  Conse- 
quently, we prepared a  monomorphic (recognizing all allotypes)  antibody for DS by 
immunizing rabbits with purified I-A molecules from marmoset. Although the studies 
described  here  only  demonstrate  the  reactivity  of Rb03  with  DS  molecules  from 
GM3107 (DR2)  and  GM3163(DR7)  cells,  additional  studies  (unpublished)  demon- 
strate that Rb03 also reacts with DS molecules from DR1, DR3, and DR4 cell lines. 
Biochemical  analysis  of human  DS  molecules  using  both  SG171  and  the  rabbit 
anti-I-A  antiserum  provides  an  explanation  for  the  failure  of others  to  detect  it. 
Although  the  murine  I-A and  I-E  molecules  are  easily  discernible  by  SDS-PAGE 
when  analyzed under appropriate  conditions,  the same is  not  true  for their  human 
equivalents.  Based on 2-D gel analysis,  the human DSfl subunits  have virtually the 
same  size  as  the  DRfl  subunits  and  are  also  closely  related  in  charge.  We  were 
fortunate that the DS7 fl subunit  is quite a  bit more basic than  the DR7 fl subunit, 
allowing  us  to  easily  distinguish  the  two.  In  contrast,  the  DS2  fl  subunit  (from 
GM3107, a DR2 cell line) has virtually the same charge as the DR2 fl subunit. As for 
the a  subunits, the DS and DR a  subunits are indistinguishable  under the conditions 
used in this study. In view of the similarity in size and charge of human DR and DS 
molecules,  it  is  quite  likely  that  other  investigators  have  produced  monoclonal 
antibodies to DS and incorrectly deduced that they were directed against DR. Indeed, 
it should be pointed out that others have described the existence of multiple human 
Ia-like molecules  (42-47); however, it is not clear whether these represent  additional 
families  of DR-like  molecules  or whether  some  of them  are  equivalent  to  the  DS 
molecules described here. 
The observation  that  SG171  reacts with  DS molecules  found only in conjunction 
with  DR7  and  that  these  DS7  molecules  isolated  from all  three  DR7  cell  lines  are 
identical strongly suggests that DS is closely linked to DR. This is entirely consistent 
with  the  genetic  organization  of murine  Ia  molecules,  where  the  polymorphic  (fl) 
subunit of I-E molecules is tightly linked to I-A molecules (31, 32). Furthermore,  the 562  HLA-DS, A SECOND FAMILY OF HUMAN Ia MOLECULES 
observed polymorphism of DSa subunits is consistent with the observed polymorphism 
of murine  I-A  subregion  a  subunits  (25).  The  existence of a  second  group  of Ia 
molecules (DS) closely linked to DR but nevertheless structurally distinct may provide 
an explanation for observations suggesting nonidentity of the HLA-D locus (defined 
by MLR reactions) and the HLA-DR locus (defined serologically) (48-50), i.e., some 
HLA-D determinants may represent antigenic specificities expressed by the closely 
linked DS molecules. Biochemical analysis of Ia molecules isolated from such individ- 
uals should provide an answer to this enigma. Of equal importance is the question of 
whether the DS  molecules defined here are  equivalent  to  the DCI,  MB,  and  MT 
molecules defined by others as Ia-like molecules closely linked to HLA-DR  (51-53). 
Experiments directed at resolving this question are presently under way. 
The cross-reaction of SG171 with DS7 and DR molecules is surprising in view of 
their  structural  dissimilarity.  However,  there  are  several  other  examples  in  the 
literature of cross-reactions between murine I-A and  I-E  molecules  (54-56).  These 
cross-reactions suggest that, despite apparent structural dissimilarity, the DS and DR 
molecules might have evolved from a common ancestral gene. 
The cross-reactivity of DS7 with HLA-DR points out a dilemma confronted by the 
immune system of individuals possessing the DS7 allotype. If, as data in mice suggest, 
specific recognition of self I-A is  a  requisite for cell cooperation, then,  clearly, the 
epitope seen by SG171  on DS7 cannot be used for specific recognition of the DS7 
molecules by T  cell  receptors specific  for self I-A.  Otherwise,  I-A  restriction,  i.e., 
recognition of self I-A molecules in an allotype-specific fashion, would not be observed 
among DS7  individuals.  This reasoning,  extended to its  logical conclusion, argues 
that although a particular DS allotype may consist of several epitopes that distinguish 
it  from other allotypes, only some of these  may be used  for recognition by T  cell 
receptors. This proposal is supported by the observations of others (57,  58)  demon- 
strating the nonequivalency of different epitopes on H-2K or Ia molecules recognized 
by H-2K or I region-restricted T  cells.  The functional significance and consequences 
of this sort of constraint placed upon the immune system is as yet unclear. 
Summary 
In mice, two families of structurally distinct Ia molecules, one designated I-A and 
the  other  I-E,  have  been  identified  and  characterized.  The  HLA-DR  molecules 
represent one family of human Ia molecules equivalent to the murine I-E molecules 
on  the  basis  of amino  acid  sequence  homology.  We  describe  the  isolation  and 
biochemical characterization of a  second family of human Ia molecules, designated 
HLA-DS  for second  D-region  locus, equivalent  to  the  murine  I-A molecules.  The 
human HLA-DS molecules consist of two polypeptide chains, DSa  (37,000 mol wt) 
and DSfl (29,000 tool wt), with 73% amino acid sequence identity to the murine I-A 
molecules.  Furthermore,  the  HLA-DS  molecules  are  closely  linked  genetically  to 
HLA-DR molecules, a situation analogous to that observed in mice. The similarity in 
molecular weights of the DR and DS molecules might explain why others have failed 
to identify the latter in man. 
Note  added  in  proof" Results  of recent  2-D  gel  experiments  (S.  M.  Goyert,  M. 
Krumpton,  and J.  Silver, manuscript  submitted  for publication)  indicate that  the 
"supertypic" specificities,  DCI  and  MT3,  detected with  the  monoclonal  antibody SANNA M.  GOYERT, JOHN E.  SHIVELY,  AND JACK SILVER  563 
SDRI and the alloantiserum  Hon 7, respectively, are present on the HLA-DS family 
of molecules. Futhermore, Bona and Strominger [Nature (Lorgl.,) in press] have found 
that  the  heavy chain  of the  DCI molecule  isolated  with  the  monoclonal  antibody 
Genox 3.53 is homologous to the heavy chain of HLA-DS molecules described above. 
Received  for publication 22 March 1982 and in revised  form 18 May 1982. 
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